Program

Last Updated: 14 July, 2011

The meeting will begin with an welcome reception in the Oriental International Convention Hotel on the evening of July 24, 2011.  The scientific meeting will be held in the Guangzhou Baiyun International Convention Center (attached to the hotel) two full days, July 25 - 26, 2011.  

            July 24, 2011            6:00 PM - 7:00 PM   Registration (Pick up Meeting Materials)
                                            7:00 PM - 8:30 PM   Welcome Networking Reception 

            July 25, 2011            8:30 AM - 6:15 PM   Morning and Afternoon Scientific Sessions
                                            Optional SCBA Banquet (Tickets will be available in the Convention Center)

            July 26, 2011            8:30 AM - 6:10 PM   Morning and Afternoon Scientific Sessions

Click For Final Meeting Agenda                                     
          

PRELIMINARY    Monday, July 25

 

8:30 – 8:35 AM     Welcome and Announcements           
                                Doug Lowy, NCI


SESSION I
Chairs: TC Wu and Yi-min Shao


8:35 – 9:00 AM     Ubiquitination and SUMOylation of Influenza viral proteins Regulate Viral Replication (1566)
                                    Michael M.C. Lai, Academia Sinica
9:00 – 9:25 AM     Early Events in Poxvirus Replication: Entry and Gene Expression (1579)
                                    Bernard Moss, NIAID, NIH
9:25 – 9:50 AM     Measles Pathogenesis: Virus clearance and complications (1564)
                                    Diane Griffin, Johns Hopkins Bloomberg School of Public Health
9:50 – 10:15 AM   Regaulation of Hepatitis B Virus Transcription by Sex Hormones (1568)
                                    Pei-Jer Chen, National Taiwan University and Hospital

10:15 – 10:25 AM Morning Break


SESSION II 
Chairs: Zhi-ming Chang and Udaykumar Ranga


10:25 – 10:40 AM Coordination of the canonical and noncanonical NF-kappaB pathways in HTLV-I/Tax-mediated 
                                tumorigenesis
(1563)
                                    Gutian Xiao, University of Pittsburgh
10:40 – 10:55 AM Ubiquitin-specific peptidase 20 (USP20) suppresses NF-kappaB pathway by targeting TRAF6 
                                and HTLV-1 Tax
(1582)
                                    Junichiro Yasunaga, Kyoto University
10:55 – 11:10 AM Influenza A Virus NS1 Protein Suppresses NF-?B-mediated Innate Immune Response by Disruption 
                                of IKK
(1576)
                                    Shijuan Gao, Chinese Academy of Sciences
11:10 – 11:25 AM Host receptor tyrosine kinase signaling pathways required for influenza virus replication (1574)
                                    Yuying Liang, Emory University
11:25 – 11:40 AM The roles of viral determinants and host factor regulation in influenza A virus pathogenesis (1589)
                                    Honglin Chen, The University of Hong Kong


11:40 AM – 1:00 PM Lunch (on your own)


SESSION III
Chairs: Yi-ming Chen and Eliza Vicenzi

1:00 – 1:25 PM     Essential Cell Genes for Signaling from the EBV Oncogene LMP1 (1700)
                                    Elliott Kieff, Harvard
1:25 – 1:50 PM     Use of proteomic arrays to identify common herpesvirus host pathway interactions (1570)
                                    S Diane Hayward, The Johns Hopkins University
1:50 – 2:15 PM     The Acute HIV Infection: Implications For Intervention, Prevention and Development of an Effective 
                                 AIDS Vaccine
(1593)
                                    Malcolm Martin, NIAID, NIH
2:15 – 2:40 PM     Vaccination studies with a drug-controlled SIV variant (1602) 
                                    Ben Berkhout, University of Amsterdam
2:40 – 2:55 PM     Comprehensive Characterization of Human Cytomegalovirus Infection in the Long-term Infected T98G 
                                Cell Model (1577)
                                    Min Hua Luo, Wuhan Institute of Virology, Chinese Academy of Sciences
2:55 – 3:10 PM     Targeting Epstein-Barr virus lytic cycle induction in nasopharyngeal carcinoma by suberoylanilide 
                                hydroxamic acid 
(1613)
                                    Alan Chiang, The University of Hong Kong


3:10 – 4:00 PM    Poster Session I and Coffee Break


SESSION IV
Chairs: Shibo Jiang and Damian Purcell


4:00 – 4:15 PM    Comprehensive analysis of pathogen-specific polyclonal antibody response in vivo based on a 
                                combinatorial antigen library displayed on the surface of yeast Saccharomyces cerevisiae
(1571)
                                    Linqi Zhang, School fo Medicine, Tsinghua University
4:15 – 4:30 PM     Multiple HIV restriction pathways in M1 and M2 polarized human monocyte-derived macrophages (1580)
                                    Guido Poli, Vita-Salute San Raffaele University
4:30 – 4:45 PM     HIV-associated cholesterol is not needed for viral entry but is important for post-entry regulation (1585)
                                    Johnson Mak, Burnet Institute
4:45 – 5:00 PM    Virological Characterization and Drug Susceptibilities of HIV-1 CRF07_BC Strains from Treatment-naïve 
                                Patients in Taiwan
(1598)
                                    Yi-Ming Chen, National Yang-Ming University
5:00 – 5:15 PM     Replicating adenovirus-SIV recombinant priming and protein boosting elicits mucosal IgA immunity in 
                                macaques correlated with delayed acquisition after a repeated, low dose, rectal SIVmac251 
                                challenge
(1622)
                                    Jean Patterson, NIH, NCI, Vaccine Branch
5:15 – 5:30 PM     Transcription factor binding site polymorphism in the viral promoter of HIV-1 subtype C (1634)
                                    Udaykumar Ranga, Jawaharlal Nehru Centre for Advanced Scientific Research
5:30 – 5:45 PM     HIV, Substance Abuse and Neuroinflammation (1592)
                                    Anil Kumar, UMKC
5:45 – 6:00 PM     Development of human neutralizing monoclonal antibodies from convalescent patient recovered from HPAI 
                                H5N1 virus infection
(1595)
                                    Hong Xing Hu, Institut Pasteur of Shanghai, Chinese Academy of Sciences
6:00 – 6:15 PM     Early childhood infection by the Kapsosi’s sarcoma associated human herpesvirus in sub-Saharan Africa: 
                                Zambia 
(1624)
                                    Charles Wood, University of Nebraska – Lincoln

 

PRELIMINARY    tuesday, July 26

 

SESSION V
Chairs: Guido Poli and Charles Wood
 

8:30 – 8:55 AM     Tipping the Antiviral Innate Immunity Balance: Opposing Roles of the Interferon Inducible ADAR1 RNA 
                                Adenosine 
Deaminase and PKR Protein Kinase during Viral Infection (1569)
                                    Charles Samuel, University of California, Santa Barbara
8:55 -9:20 AM      Protein kinase R control of viral entry via modulation of the actin-regulatory protein gelsolin (1640)
                                    Bryan Williams, Monash Institute of Medical Research
9:20 – 9:45 AM   RIG-I and MDA5 require a double-stranded RNA-binding partner for activation of innate antiviral response (1629)
                                    Dong-Yan Jin, The University of Hong Kong
9:45 – 10:10 AM Current and future preventive HPV vaccines (1702)
                                    Doug Lowy, NCI
 

10:10 – 10:20 AM Morning Break
 

SESSION VI
Chairs: Gutian Xiao and Linqi Zhang
 

10:20 – 10:35 AM Structure-Function Analysis of Lassa Nucleoprotein Required for Viral Replication and Host Innate Immune 
                                Evasion
(1575)
                                    Hinh Ly, Emory University School of Medicine
10:35 -10:50 AM Histone deacetylase inhibitors control splicing of latent HIV-1 mRNA (1641)
                                    Damian Purcell, University of Melbourne
10:50 – 11:05 AM  Research and development of HA1 fusion protein-based H5N1 influenza vaccines (1637)
                                    Shibo Jiang, Shanghai Medical College, Fudan University
11:05 -11:20 AM  Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during 
                                Crimean-Congo hemorrhagic fever virus infection
(1617)
                                    Yee-Joo Tan, National University of Singapore
11:20 – 11:35 AM Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use 
                                with Inactivated or Adenovirus Vaccines
(1587)
                                    Suh-Chin Wu, National Tsing Hua University
 

11:35 AM – 1:00 PM Lunch (on your own)
 

SESSION VII
Chairs: Zhihong Hu and Junichiro Yasunaga

1:00 – 1:25 PM     Competitive Inhibition of Mcl-1 Ubiquitination by Enterovirus 71 2B and Correlation between Enterovirus 71 3C 
                                Activities with Clinical Neurologic Involvement
(1701)
                                    Li-min Huang, National Taiwan University
1:25 – 1:50 PM    Molecular mechanisms of pathogenesis by human T-cell leukemia virus type 1 (1565)
                                    Masao Matsuoka, Institute for Virus Research, Kyoto University
1:50 -2:15 PM      Roles of microRNAs and tumor suppressors in HTLV induced cell growth dysregulation (1618)
                                    Kuan-Teh Jeang, NIAID, NIH
2:15 -2:30 PM      Nucleolin is required for Dengue 2 virus replication and  associates with viral RNA and  NS5 protein (1703)
                                    Yingfeng Lei, the Fourth Military Medical University
2:30 – 2:45 PM   Lectin array profiling on ATL cells: Implications for clinical use of sugar chains as diagnostic markers (1591)
                                    Hidekatsu Iha, Oita University Faculty of Medicine
2:45 – 3:00 PM   Pandemic Influenza Vaccination Preferentially Induces Hetero-Subtypic Antibody Responses Against Group 1 
                              Influenza A Viruses
(1615)
                                    Elisa Vicenzi, San Raffaele Scientific Institute
 

3:00 – 4:00 PM  Poster Session II and Coffee Break
 

SESSION VIII
Chairs: Kanghong Hu and Takao Kinjo
 

4:00 – 4:15 PM   Spontaneous development of B-cell lymphomas by persistent expression of the full genome of hepatitis C virus 
                                in B cells in mice
(1572)
                                    Kyoko Kohara, Kumamoto University
4:15 – 4:30 PM     Recombinant human enterovirus 71(HEV71) VP1 protein may enhance inactived HEV71 vaccine immunization 
                                
(1596)
                                    Mingfei Jin, Shanghai Institutes for Biological Sciences
4:30 – 4:45 PM     MicroRNA Binding Sites In Interleukin-6 (IL-6) Open Reading Frame Play Pivotal Roles In Viral Induction Of IL-6 
                                Expression
(1606)
                                    Zhi-Ming Zheng, National Cancer Institute
4:45 – 5:00 PM   Optimisation of the shRNA design for RNAi-mediated inhibition of HIV-1 (1620)
                                    Ying Poi Liu, Academic Medical Center, University of Amsterdam
5:00 – 5:15 PM   Evidence for sequence specific evolution of HIV RNA by cellular miRNA-based selection (1621)
                                    Laurent Houzet, NIAID, NIH
5:15 – 5:30 PM   The essential ubiquitin modification for HIV-1 Vif to induce APOBEC3G degradation (1625)
                                    Bindong Liu, Meharry Medical College
5:30 – 5:45 PM   Subcellular Localization of Hepatitis C Virus NS3 Protein Determines its Biological Functions in Viral Life Cycle 
                               
(1610) 
                                    Ying He, Institute Pasteur of Shanghai
5:45 – 6:00 PM     Hepatitis B Surface Antigen (HBsAg) Promotes a Chaperon Protein GRP78 Secretion: Association with Higher 
                                Susceptibility to Liver Toxicity
(1608)
                                    Chao Zhao, Shanghai Medical College, Fudan University
6:00 – 6:05 PM    Closing Remarks 
                                    Doug Lowy, NCI and Kuan-Teh Jeang, NIAID 

Questions? Email us